Colgate Announces Strong 2nd Quarter Results
Worldwide Net Sales Up 9.5%, Diluted EPS Up 8%
Net income increased 3% to
Gross profit margin was 57.4%, down 140 basis points versus the year ago quarter, as higher material costs more than offset benefits from cost savings from the Company's funding-the-growth initiatives.
Selling, general and administrative expenses increased by 10 basis
points to 34.0% of net sales in second quarter 2011 from 33.9% in second
quarter 2010, as worldwide advertising spending increased 11% versus the
year ago quarter to
Operating profit increased 2% to
Net cash provided by operations year to date was
As previously announced, as part of its strategy to focus on its
higher-margin oral care, personal care and pet nutrition businesses, on
Also as previously announced, in connection with the
"Pleasingly, organic sales worldwide grew 3.5% during the quarter, driven by unit volume increases across all operating divisions and a return to positive pricing on a global basis.
"Colgate's global market shares in toothpaste and manual toothbrushes are both at record highs year to date. Colgate's share of the global toothpaste market strengthened to 44.6% year to date, up 0.4 share points versus year ago. Our global leadership in manual toothbrushes also strengthened during the quarter with Colgate's global market share in that category reaching 31.9% year to date, up 0.7 share points versus year ago.
"Advertising spending increased both absolutely and as a percent to sales versus the year ago quarter, and we continue to plan for higher levels of spending in the second half of the year versus the first, in support of a very full pipeline of new products.
"Reflecting the significantly higher cost environment, we continue to
expect gross profit margin for the year to decline between 80 and 100
basis points versus 2010. We continue to be sharply focused on our
aggressive funding-the-growth initiatives and anticipate that the
benefits from those programs combined with our strategic worldwide
pricing efforts will help us achieve our profit target of mid-single
digit earnings per share growth for the year, excluding the previously
disclosed charge relating to the transition to hyperinflationary
accounting in
At
The following are comments about divisional performance. See attached Geographic Sales Analysis and Segment Information schedules for additional information on divisional sales and operating profit.
North
Operating profit in
In the U.S., new product launches including Colgate Sensitive Multi Protection and Colgate Max Clean SmartFoam toothpastes and the relaunch of Colgate Total toothpaste are strengthening Colgate's leadership in toothpaste, with its share of that market reaching 36.0% year to date, up 0.6 share points versus year ago. Colgate's strength in manual toothbrushes also continued, driven by the success of Colgate 360° Surround, Colgate 360° ActiFlex, Colgate Total and Colgate Extra Clean manual toothbrushes.
Successful new products in the U.S. in other categories include Softsoap brand Body Butter Strawberry Smoother body wash and Palmolive Soft Touch with Vitamin E dish liquid.
Looking ahead in the U.S., an array of new product introductions are planned for the balance of the year with strong advertising supporting them and other recent new product launches. Third quarter launches include Colgate Optic White toothpaste and manual toothbrush, Palmolive Pomegranate dish liquid, Softsoap brand Eucalyptus and Aloe liquid hand soap and a new line of Softsoap brand bar soaps.
Latin
Operating profit in
Colgate's strong leadership in oral care throughout
Products in other categories contributing to market share gains included
Palmolive Naturals Relaxing Softness Cream and Lavender and Protex
Advanced Clean bar soaps, and
Operating profit in
Colgate strengthened its oral care leadership in the
Recent premium innovations contributing to strength in other product
categories include
While Operating profit in
Colgate continued its toothpaste leadership in
Successful products contributing to growth in other categories in the
region include Colgate 360° Surround and Colgate Massager manual
toothbrushes, Colgate Plax Sensitive and Colgate Plax Complete Care
mouthwashes,
Hill's (13% of Company Sales)
Hill's Net sales grew 9.5% during the quarter. Unit volume increased
2.0%, pricing increased 1.5% and foreign exchange was positive 6.0%.
Volume gains led by
While Hill's Operating profit increased 5% in the second quarter of 2011
to
Recent new product introductions contributing to sales in the U.S.
include Science Diet Ideal Balance Canine, which combines natural
ingredients with the power of advanced nutrition in one balanced
package, Science Diet Savory Stew Canine, Science Diet Age Defying
Feline and the relaunch of Prescription Diet c/d
New pet food products contributing to international sales include
Science Diet Senior Advanced (15 years plus) Canine and Feline, Science
Diet Sterilized Cat and the relaunch of Prescription Diet c/d
***
About
Substantially all market share data included in this press release is
compiled from data as measured by
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast (other than historical
information) may contain forward-looking statements. Such statements may
relate, for example, to sales or unit volume growth, organic sales
growth, profit or profit margin growth, earnings growth, financial
goals, the impact of currency devaluations or exchange controls in
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
To supplement Colgate's condensed income statements presented in
accordance with accounting principles generally accepted in
This release discusses organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and divestments. Management believes this measure provides investors with useful supplemental information regarding the Company's underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See "Geographic Sales Analysis, Percentage Changes — Second Quarter 2011 vs. 2010" for a comparison of organic sales growth to sales growth in accordance with GAAP.
The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as net cash provided
by operations less capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See "Condensed Consolidated Statements of
Cash Flows For the Six Months Ended
(See attached tables for second quarter results.)
Table 1 | ||||||||||||||
Colgate-Palmolive Company | ||||||||||||||
Consolidated Income Statements | ||||||||||||||
For the Three Months Ended June 30, 2011 and 2010 | ||||||||||||||
(in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||
2011 | 2010 | |||||||||||||
Net sales | $ | 4,185 | $ | 3,814 | ||||||||||
Cost of sales | 1,781 | 1,572 | ||||||||||||
Gross profit | 2,404 | 2,242 | ||||||||||||
Gross profit margin | 57.4 | % | 58.8 | % | ||||||||||
Selling, general and administrative expenses | 1,421 | 1,292 | ||||||||||||
Other (income) expense, net | 15 | 2 | ||||||||||||
Operating profit | 968 | 948 | ||||||||||||
Operating profit margin | 23.1 | % | 24.9 | % | ||||||||||
Interest expense, net | 11 | 14 | ||||||||||||
Income before income taxes | 957 | 934 | ||||||||||||
Provision for income taxes | 311 | 304 | ||||||||||||
Effective tax rate | 32.5 | % | 32.5 | % | ||||||||||
Net income including noncontrolling interests | 646 | 630 | ||||||||||||
Less: Net income attributable to noncontrolling interests | 24 | 27 | ||||||||||||
Net income attributable to Colgate-Palmolive Company | $ | 622 | $ | 603 | ||||||||||
Earnings per common share | ||||||||||||||
Basic | $ | 1.27 | $ | 1.21 | ||||||||||
Diluted | $ | 1.26 | $ | 1.17 | ||||||||||
Average common shares outstanding | ||||||||||||||
Basic | 489.5 | 490.1 | ||||||||||||
Diluted | 493.3 | 514.7 | ||||||||||||
Table 2 |
||||||||||||||
Colgate-Palmolive Company | ||||||||||||||
Consolidated Income Statements | ||||||||||||||
For the Six Months Ended June 30, 2011 and 2010 | ||||||||||||||
(in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||||
2011 | 2010 | |||||||||||||
Net sales | $ | 8,179 | $ | 7,643 | ||||||||||
Cost of sales | 3,444 | 3,133 | ||||||||||||
Gross profit | 4,735 | 4,510 | ||||||||||||
Gross profit margin | 57.9 | % | 59.0 | % | ||||||||||
Selling, general and administrative expenses | 2,825 | 2,647 | ||||||||||||
Other (income) expense, net | 27 | 237 | ||||||||||||
Operating profit | 1,883 | 1,626 | ||||||||||||
Operating profit margin | 23.0 | % | 21.3 | % | ||||||||||
Interest expense, net | 27 | 30 | ||||||||||||
Income before income taxes | 1,856 | 1,596 | ||||||||||||
Provision for income taxes | 603 | 579 | ||||||||||||
Effective tax rate | 32.5 | % | 36.3 | % | ||||||||||
Net income including noncontrolling interests | 1,253 | 1,017 | ||||||||||||
Less: Net income attributable to noncontrolling interests | 55 | 57 | ||||||||||||
Net income attributable to Colgate-Palmolive Company | $ | 1,198 | $ | 960 | ||||||||||
Earnings per common share | ||||||||||||||
Basic | $ | 2.44 | $ | 1.92 | ||||||||||
Diluted | $ | 2.42 | $ | 1.86 | ||||||||||
Average common shares outstanding | ||||||||||||||
Basic | 491.5 | 491.9 | ||||||||||||
Diluted | 494.9 | 516.7 | ||||||||||||
Table 3 | |||||||||||||||||||||
Colgate-Palmolive Company | |||||||||||||||||||||
Non-GAAP Reconciliation | |||||||||||||||||||||
For the Six Months Ended June 30, 2011 and 2010 | |||||||||||||||||||||
(in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||
2011 | 2010 | ||||||||||||||||||||
As Reported |
As Reported 1 |
Venezuela Hyperinflationary 2 |
As Adjusted Non-GAAP 1 |
||||||||||||||||||
Other (income) expense, net | $ | 27 | $ | 237 | $ | 271 | $ | (34 | ) | ||||||||||||
Operating profit | 1,883 | 1,626 | (271 | ) | 1,897 | ||||||||||||||||
Operating profit margin | 23.0 | % | 21.3 | % | 24.8 | % | |||||||||||||||
Income before income taxes | 1,856 | 1,596 | (271 | ) | 1,867 | ||||||||||||||||
Effective tax rate | 32.5 | % | 36.3 | % | 31.0 | % | |||||||||||||||
Net income including noncontrolling interests | 1,253 | 1,017 | (271 | ) | 1,288 | ||||||||||||||||
Net income attributable to Colgate-Palmolive Company | $ | 1,198 | $ | 960 | $ | (271 | ) | $ | 1,231 | ||||||||||||
Earnings per common share 3 | |||||||||||||||||||||
Basic | $ | 2.44 | $ | 1.92 | $ | (0.55 | ) | $ | 2.47 | ||||||||||||
Diluted | $ | 2.42 | $ | 1.86 | $ | (0.52 | ) | $ | 2.38 | ||||||||||||
1 |
Includes a $46 pretax ($59 aftertax, $0.11 diluted earnings per share) gain related to the remeasurement of the Venezuelan balance sheet and lower taxes on accrued but unpaid remittances resulting from the currency devaluation in January 2010. |
|
2 |
Represents the one-time charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. This amount primarily represents the premium paid to acquire U.S. dollar-denominated cash and bonds. Prior to January 1, 2010, these assets had been remeasured at the parallel market rate and then translated for financial reporting purposes at the official rate of 2.15. |
|
3 |
The impact of Non-GAAP adjustments on the basic and diluted earnings per share may not necessarily equal the difference between "As Reported" and "As Adjusted Non-GAAP" as a result of rounding. |
|
|
Table 4 |
||||||||||||||||||
Colgate-Palmolive Company | ||||||||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||||||||
As of June 30, 2011, December 31, 2010 and June 30, 2010 | ||||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||||
June 30, |
December 31, |
June 30, |
||||||||||||||||
2011 | 2010 | 2010 | ||||||||||||||||
Cash and cash equivalents | $ | 739 | $ | 490 | $ | 555 | ||||||||||||
Receivables, net | 1,819 | 1,610 | 1,594 | |||||||||||||||
Inventories | 1,417 | 1,222 | 1,246 | |||||||||||||||
Other current assets | 495 | 408 | 416 | |||||||||||||||
Property, plant and equipment, net | 3,831 | 3,693 | 3,410 | |||||||||||||||
Other assets, including goodwill and intangibles | 4,943 | 3,749 | 3,365 | |||||||||||||||
Total assets | $ | 13,244 | $ | 11,172 | $ | 10,586 | ||||||||||||
Total debt | 5,011 | 3,424 | 3,373 | |||||||||||||||
Other current liabilities | 3,258 | 3,119 | 2,913 | |||||||||||||||
Other non-current liabilities | 1,831 | 1,812 | 1,496 | |||||||||||||||
Total liabilities | 10,100 | 8,355 | 7,782 | |||||||||||||||
Total Colgate-Palmolive Company shareholders' equity | 2,969 | 2,675 | 2,632 | |||||||||||||||
Noncontrolling interests | 175 | 142 | 172 | |||||||||||||||
Total liabilities and shareholders' equity | $ | 13,244 | $ | 11,172 | $ | 10,586 | ||||||||||||
Supplemental Balance Sheet Information | ||||||||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 4,219 | $ | 2,860 | $ | 2,764 | ||||||||||||
Working capital % of sales | 2.5 | % | 0.3 | % | 1.9 | % | ||||||||||||
* |
Marketable securities of $53, $74 and $54 as of June 30, 2011, December 31, 2010 and June 30, 2010, respectively, are included in Other current assets. |
|
|
Table 5 | ||||||||||||
Colgate-Palmolive Company | ||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||
For the Six Months Ended June 30, 2011 and 2010 | ||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
Six Months Ended | ||||||||||||
June 30, | ||||||||||||
2011 | 2010 | |||||||||||
Operating Activities | ||||||||||||
Net income including noncontrolling interests | $ | 1,253 | $ | 1,017 | ||||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: |
||||||||||||
Depreciation and amortization | 202 | 185 | ||||||||||
Venezuela hyperinflationary transition charge | - | 271 | ||||||||||
Stock-based compensation expense | 56 | 60 | ||||||||||
Deferred income taxes | 46 | 55 | ||||||||||
Cash effects of changes in: | ||||||||||||
Receivables | (153 | ) | (35 | ) | ||||||||
Inventories | (148 | ) | (85 | ) | ||||||||
Accounts payable and other accruals | (50 | ) | (206 | ) | ||||||||
Other non-current assets and liabilities | (52 | ) | 40 | |||||||||
Net cash provided by operations |
1,154 | 1,302 | ||||||||||
Investing Activities | ||||||||||||
Capital expenditures | (225 | ) | (204 | ) | ||||||||
Purchases of marketable securities and investments | (80 | ) | (13 | ) | ||||||||
Proceeds from marketable securities and investments | 171 | - | ||||||||||
Payment for acquisitions, net of cash acquired |
(960 | ) | - | |||||||||
Other | (17 | ) | 2 | |||||||||
Net cash used in investing activities |
(1,111 | ) | (215 | ) | ||||||||
Financing Activities | ||||||||||||
Principal payments on debt | (1,869 | ) | (2,514 | ) | ||||||||
Proceeds from issuance of debt | 3,433 | 2,757 | ||||||||||
Dividends paid | (568 | ) | (520 | ) | ||||||||
Purchases of treasury shares | (1,017 | ) | (978 | ) | ||||||||
Proceeds from exercise of stock options and excess tax benefits | 220 | 141 | ||||||||||
Net cash provided by (used in) financing activities |
199 | (1,114 | ) | |||||||||
Effect of exchange rate changes on Cash and cash equivalents | 7 | (18 | ) | |||||||||
Net increase (decrease) in Cash and cash equivalents | 249 | (45 | ) | |||||||||
Cash and cash equivalents at beginning of period | 490 | 600 | ||||||||||
Cash and cash equivalents at end of period | $ | 739 | $ | 555 | ||||||||
Supplemental Cash Flow Information | ||||||||||||
Free cash flow before dividends (Net cash provided by operations less capital expenditures) | ||||||||||||
Net cash provided by operations | $ | 1,154 | $ | 1,302 | ||||||||
Less: Capital expenditures | (225 | ) | (204 | ) | ||||||||
Free cash flow before dividends | $ | 929 | $ | 1,098 | ||||||||
Income taxes paid | $ | 513 | $ | 621 | ||||||||
Table 6 | ||||||||||||||||||||||
Segment Information | ||||||||||||||||||||||
For the Three and Six Months Ended June 30, 2011 and 2010 | ||||||||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||||||||
Net sales | ||||||||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||||||||
North America | $ | 744 | $ | 768 | $ | 1,462 | $ | 1,521 | ||||||||||||||
Latin America | 1,231 | 1,055 | 2,328 | 2,061 | ||||||||||||||||||
Europe/South Pacific | 857 | 770 | 1,689 | 1,594 | ||||||||||||||||||
Greater Asia/Africa | 816 | 730 | 1,629 | 1,460 | ||||||||||||||||||
Total Oral, Personal and Home Care | 3,648 | 3,323 | 7,108 | 6,636 | ||||||||||||||||||
Pet Nutrition | 537 | 491 | 1,071 | 1,007 | ||||||||||||||||||
Total Net sales | $ | 4,185 | $ | 3,814 | $ | 8,179 | $ | 7,643 | ||||||||||||||
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||||||||
Operating profit | ||||||||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||||||||
North America | $ | 194 | $ | 227 | $ | 386 | $ | 444 | ||||||||||||||
Latin America 1 | 360 | 303 | 686 | 643 | ||||||||||||||||||
Europe/South Pacific | 170 | 184 | 355 | 375 | ||||||||||||||||||
Greater Asia/Africa | 199 | 189 | 402 | 378 | ||||||||||||||||||
Total Oral, Personal and Home Care | 923 | 903 | 1,829 | 1,840 | ||||||||||||||||||
Pet Nutrition | 140 | 134 | 281 | 275 | ||||||||||||||||||
Corporate 2 | (95 | ) | (89 | ) | (227 | ) | (489 | ) | ||||||||||||||
Total Operating profit |
$ | 968 | $ | 948 | $ | 1,883 | $ | 1,626 | ||||||||||||||
Note: | The Company evaluates segment performance based on several factors, including Operating profit. | |
The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. |
||
1 | Latin America Operating profit for the six months ended June 30, 2010 includes a $46 pretax gain resulting from the currency devaluation in Venezuela on January 8, 2010. | |
2 | Corporate operations include stock-based compensation related to stock options and restricted stock awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. In 2010, Corporate Operating profit also includes a one-time $271 charge related to the transition to hyperinflationary accounting in Venezuela as of January 1, 2010. | |
Table 7 | ||||||||||||||||||||||||||||||
Colgate-Palmolive Company | ||||||||||||||||||||||||||||||
Geographic Sales Analysis | ||||||||||||||||||||||||||||||
Percentage Changes - Second Quarter 2011 vs 2010 | ||||||||||||||||||||||||||||||
June 30, 2011 | ||||||||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||||
SECOND QUARTER | SIX MONTHS | |||||||||||||||||||||||||||||
Pricing | Pricing | |||||||||||||||||||||||||||||
2nd Qtr | Coupons | 6 Months | Coupons | |||||||||||||||||||||||||||
Sales | 2nd Qtr | Consumer & | Sales | 6 Months | Consumer & | |||||||||||||||||||||||||
Change | Organic | Trade | Change | Organic | Trade | |||||||||||||||||||||||||
Region |
As Reported | Sales Change | Volume | Incentives | Exchange | As Reported | Sales Change | Volume | Incentives | Exchange | ||||||||||||||||||||
Total Company | 9.5 | % | 3.5 | % | 3.0 | % | 0.5 | % | 6.0 | % | 7.0 | % | 2.5 | % | 2.5 | % | 0.0 | % | 4.5 | % | ||||||||||
Europe/South Pacific | 11.5 | % | (2.0 | %) | 0.5 | % | (2.5 | %) | 13.5 | % | 6.0 | % | (2.0 | %) | 0.5 | % | (2.5 | %) | 8.0 | % | ||||||||||
Latin America | 17.0 | % | 10.5 | % | 4.0 | % | 6.5 | % | 6.5 | % | 13.0 | % | 7.5 | % | 2.0 | % | 5.5 | % | 5.5 | % | ||||||||||
Greater Asia/Africa | 12.0 | % | 6.5 | % | 6.5 | % | 0.0 | % | 5.5 | % | 11.5 | % | 7.0 | % | 7.5 | % | (0.5 | %) | 4.5 | % | ||||||||||
Total International | 13.5 | % | 5.5 | % | 3.5 | % | 2.0 | % | 8.0 | % | 10.5 | % | 4.5 | % | 3.0 | % | 1.5 | % | 6.0 | % | ||||||||||
North America | (3.0 | %) | (4.0 | %) | 0.5 | % | (4.5 | %) | 1.0 | % | (4.0 | %) | (4.5 | %) | 0.0 | % | (4.5 | %) | 0.5 | % | ||||||||||
Total CP Products | 10.0 | % | 3.5 | % | 3.0 | % | 0.5 | % | 6.5 | % | 7.0 | % | 2.5 | % | 2.5 | % | 0.0 | % | 4.5 | % | ||||||||||
Hill's | 9.5 | % | 3.5 | % | 2.0 | % | 1.5 | % | 6.0 | % | 6.5 | % | 2.5 | % | 2.5 | % | 0.0 | % | 4.0 | % | ||||||||||
Emerging Markets (1) | 15.0 | % | 9.0 | % | 5.5 | % | 3.5 | % | 6.0 | % | 12.5 | % | 7.0 | % | 4.5 | % | 2.5 | % | 5.5 | % | ||||||||||
Developed Markets | 4.5 | % | (2.0 | %) | 0.5 | % | (2.5 | %) | 6.5 | % | 2.0 | % | (2.0 | %) | 0.5 | % | (2.5 | %) | 4.0 | % |
(1) Emerging Markets include Latin America, Greater Asia/Africa (excluding Japan) and Central Europe. |
or
Source:
News Provided by Acquire Media